Cochlear (FRA:OC50) Other Long-Term Liabilities : €22 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Cochlear Other Long-Term Liabilities?

Cochlear's other long-term liabilities for the quarter that ended in Jun. 2024 was €22 Mil.

Cochlear's quarterly other long-term liabilities increased from Jun. 2023 (€26 Mil) to Dec. 2023 (€29 Mil) but then declined from Dec. 2023 (€29 Mil) to Jun. 2024 (€22 Mil).

Cochlear's annual other long-term liabilities declined from Jun. 2022 (€27 Mil) to Jun. 2023 (€26 Mil) and declined from Jun. 2023 (€26 Mil) to Jun. 2024 (€22 Mil).

Cochlear Other Long-Term Liabilities Historical Data

The historical data trend for Cochlear's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cochlear Other Long-Term Liabilities Chart

Cochlear Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Other Long-Term Liabilities

Get a 7-Day Free Trial

Cochlear Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Cochlear Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Cochlear Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Cochlear's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cochlear Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cochlear Ltd (FRA:OC50) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

CHEOY:USA CHEOF:USA OC5:Germany COH:Australia

Address

1 University Avenue, Macquarie University, Sydney, NSW, AUS, 2109

Website

https://www.cochlear.com

Cochlear is the leading cochlear implant device manufacturer with around 60% global market share. Developed markets contribute 80% of group revenue where cochlear implants are the standard of care for children with severe to profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2020, 49% of revenue came from the Americas, 35% from Europe, the Middle East, and Africa, and 16% from the Asia-Pacific segment.

Cochlear Headlines

No Headlines